A cancer genome profiling (FoundationOne CDx) of the primary tumor (Figure 4) revealed pathogenic gene mutations in MSH6, PIK3CA, PTEN, 1and TP53 and pathogenic gene amplification of CCNE1. The tumor was MS-stable and TMB-high (14.5/Mb). The gene discussed is PIK3CA; the disease is neoplasm.